Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Epoch Biosciences, Inc.
Company expands fluorescent quenching detection patent portfolio
November 6th, 2004
Epoch Biosciences, Inc., (EBIO), a provider of proprietary products that accelerate genomic analysis, announced it received U.S. patent number 6,790,945 on "Fluorescent Quenching Detection Reagents and Methods." This patent further strengthens Epoch's position as a leader in nonfluorescent quenchers, including their use and development, according to the company. Nonfluorescent quenchers have become increasingly popular in genomic analysis because they reduce background fluorescence in probe-based assays and thereby increase sensitivity. U.S. patent number 6,790,945 covers a group of chemical compositions yielding nonfluorescent quenchers,...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
